Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Muscato, Gwen M."" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł :
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.
Autorzy :
Kennedy AL; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Myers KC; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Bowman J; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Institute for Protein Innovation, Boston, MA, USA.
Gibson CJ; Department of Medical Oncology, Division of Hematological Malignancies Dana-Farber Cancer Institute, Boston, MA, USA.
Camarda ND; Dana-Farber Cancer Institute, Boston, MA, USA.
Furutani E; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Muscato GM; Boston Children's Hospital, Boston, MA, USA.
Klein RH; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.
Ballotti K; Boston Children's Hospital, Boston, MA, USA.
Liu S; Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA, USA.
Harris CE; Boston Children's Hospital, Boston, MA, USA.
Galvin A; Boston Children's Hospital, Boston, MA, USA.
Malsch M; Boston Children's Hospital, Boston, MA, USA.
Dale D; Department of Internal Medicine, University of Washington, Seattle, WA, USA.
Gansner JM; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Nakano TA; Center for Cancer and Blood Disorders, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
Bertuch A; Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA.
Vlachos A; Division of Hematology/Oncology and Cellular Therapy, Cohen Children's Medical Center of New York, New Hyde Park, NY, USA.; Zucker School of Medicine at Hofstra/Northwell School of Medicine, Hempstead, NY, USA.
Lipton JM; Division of Hematology/Oncology and Cellular Therapy, Cohen Children's Medical Center of New York, New Hyde Park, NY, USA.; Zucker School of Medicine at Hofstra/Northwell School of Medicine, Hempstead, NY, USA.
Castillo P; Shands Children's Hospital, Department of Pediatrics, Division of Pediatric Hematology Oncology, University of Florida, Gainesville, FL, USA.
Connelly J; Department of Pediatrics, Division of Pediatric Hematology Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Churpek J; Department of Medicine, Section of Hematology, Oncology, and Palliative Care, The University of Wisconsin-Madison, Madison, WI, USA.
Edwards JR; Indiana Blood and Marrow Transplantation, Indianapolis, IN, USA.
Hijiya N; Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Ho RH; Department of Pediatrics, Division of Pediatric Hematology Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Hofmann I; Department of Pediatrics, Division of Pediatric Hematology/Oncology and BMT, University of Wisconsin, Madison, WI, USA.
Huang JN; Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, CA, USA.; Division of Pediatric Allergy, Immunology, and Blood & Marrow Transplantation, UCSF Benioff Children's Hospital, San Francisco, CA, USA.
Keel S; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
Lamble A; Division of Hematology-Oncology, Seattle Children's Hospital, Seattle, WA, USA.
Lau BW; Dartmouth-Hitchcock Medical Center, Pediatric Hematology Oncology, Geisel School of Medicine, Lebanon, NH, USA.; Department of Medicine, University of Florida, Gainesville, FL, USA.
Norkin M; Division of Cancer Medicine, Baptist MD Anderson Cancer Center, Jacksonville, FL, USA.
Stieglitz E; Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, CA, USA.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Stock W; Department of Medicine, University of Chicago, Chicago, IL, USA.
Walkovich K; Division of Pediatric Hematology- Oncology, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA.
Boettcher S; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Brendel C; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA.
Fleming MD; Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
Davies SM; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Weller EA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Biostatistics and Research Design Center, Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, MA, USA.
Bahl C; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Institute for Protein Innovation, Boston, MA, USA.
Carter SL; Broad Institute, Boston, MA, USA.; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA, USA.
Shimamura A; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Lindsley RC; Department of Medical Oncology, Division of Hematological Malignancies Dana-Farber Cancer Institute, Boston, MA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Feb 26; Vol. 12 (1), pp. 1334. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Clonal Hematopoiesis/*genetics
Clonal Hematopoiesis/*physiology
Shwachman-Diamond Syndrome/*genetics
Shwachman-Diamond Syndrome/*metabolism
Adolescent ; Adult ; Bone Marrow Diseases/genetics ; Bone Marrow Diseases/metabolism ; Child ; Child, Preschool ; Eukaryotic Initiation Factors/genetics ; Female ; Humans ; Infant ; Male ; Middle Aged ; Mutation ; Ribosomes/genetics ; Tumor Suppressor Protein p53/genetics ; Young Adult
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies